ITGAL and infection: Surprisingly, anti–VLA-4/LFA-1 failed to prevent CD4+ T cell migration into the brain at day 14 after infection, despite persistent changes in bacterial burdens and innate immune cell infiltrates (Figure 2D), revealing a sustained footprint with early T cell blockade.